Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weichenthal

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
Journal of the American Academy of Dermatology|October 27, 2019
Reply to: "Comment on 'Developing an international standard for the classification of surface anatomic location for use in clinical practice and epidemiologic research'"Katherine A Kenneweg, Allan C Halpern, Robert J G Chalmers, et al.
Journal of Clinical Epidemiology|January 1, 2003
Sun exposure and number of nevi in 5- to 6-year-old European childrenMadeleine Dulon, Michael Weichenthal, Maria Blettner, et al.
Journal of the American Academy of Dermatology|April 24, 2019
Developing an international standard for the classification of surface anatomic location for use in clinical practice and epidemiologic researchKatherine A Kenneweg, Allan C Halpern, Robert J G Chalmers, et al.
Inflammatory Bowel Diseases|August 7, 2003
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitisJan Wehkamp, Juergen Harder, Michael Weichenthal, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 20, 2014
To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesionsAxel Hauschild, Suephy C Chen, Michael Weichenthal, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2013
Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin--consensus of the lymphoma group of the Working Group Dermatologic OncologyChalid Assaf, Jürgen C Becker, Marc Beyer, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2009
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitisJens-Michael Jensen, Stephan Pfeiffer, Magdalena Witt, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2009
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitisJens-Michael Jensen, Stephan Pfeiffer, Magdalena Witt, et al.
The Oncologist|May 21, 2017
Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)Grant A McArthur, Peter Mohr, Paolo Antonio Ascierto, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Journal of the American Academy of Dermatology|October 27, 2019
Reply to: "Comment on 'Developing an international standard for the classification of surface anatomic location for use in clinical practice and epidemiologic research'"Katherine A Kenneweg, Allan C Halpern, Robert J G Chalmers, et al.
Journal of Clinical Epidemiology|January 1, 2003
Sun exposure and number of nevi in 5- to 6-year-old European childrenMadeleine Dulon, Michael Weichenthal, Maria Blettner, et al.
Journal of the American Academy of Dermatology|April 24, 2019
Developing an international standard for the classification of surface anatomic location for use in clinical practice and epidemiologic researchKatherine A Kenneweg, Allan C Halpern, Robert J G Chalmers, et al.
Inflammatory Bowel Diseases|August 7, 2003
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitisJan Wehkamp, Juergen Harder, Michael Weichenthal, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 20, 2014
To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesionsAxel Hauschild, Suephy C Chen, Michael Weichenthal, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2013
Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin--consensus of the lymphoma group of the Working Group Dermatologic OncologyChalid Assaf, Jürgen C Becker, Marc Beyer, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2009
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitisJens-Michael Jensen, Stephan Pfeiffer, Magdalena Witt, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2009
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitisJens-Michael Jensen, Stephan Pfeiffer, Magdalena Witt, et al.
The Oncologist|May 21, 2017
Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)Grant A McArthur, Peter Mohr, Paolo Antonio Ascierto, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 25, 2013
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)Annette Degen, Michael Weichenthal, Selma Ugurel, et al.
Pageof 17